Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Thromboprophylaxis

Back to Topics
Contents
0%

Thromboprophylaxis

Comprehensive guide to venous thromboembolism prevention in orthopaedic surgery including risk stratification, prophylaxis protocols, and evidence-based guidelines.

complete
Updated: 2026-01-02
High Yield Overview

THROMBOPROPHYLAXIS

VTE Prevention | DVT and PE | Orthopaedic Perioperative Care

40-60%DVT without prophylaxis
28-35Days extended prophylaxis
1-2%Symptomatic PE risk
LMWHGold standard

VTE Risk by Procedure

Very High
PatternTHA, TKA, hip fracture
TreatmentExtended prophylaxis 35 days
High
PatternMajor trauma, spine surgery
TreatmentIn-hospital + extended
Moderate
PatternFoot/ankle, upper limb
TreatmentIn-hospital or aspirin
Low
PatternMinor procedures
TreatmentEarly mobilization only

Critical Must-Knows

  • High Risk Procedures: THA, TKA, hip fracture surgery require extended prophylaxis 28-35 days
  • Mechanical: TED stockings + IPC - ALWAYS use with chemical for high-risk procedures
  • Chemical Options: LMWH (enoxaparin), DOACs (rivaroxaban, apixaban), aspirin
  • Duration: 28-35 days for THA/TKA/hip fracture - NOT just in-hospital
  • Timing: Start LMWH 6-12 hours post-op; rivaroxaban 6-10 hours post-op

Examiner's Pearls

  • "
    Extended prophylaxis 28-35 days is MANDATORY
  • "
    LMWH is gold standard but DOACs are equivalent
  • "
    Aspirin is acceptable after initial anticoagulant
  • "
    Mechanical prophylaxis ALWAYS - even if on chemical

Clinical Imaging

Imaging Gallery

Computed tomography angiography of the carotid arteries. A large embolus in the left carotid artery (arrowhead) is present.
Click to expand
Computed tomography angiography of the carotid arteries. A large embolus in the left carotid artery (arrowhead) is present.Credit: Sasaki Y et al. via Case Rep Nephrol Urol via Open-i (NIH) (Open Access (CC BY))

Critical VTE Prophylaxis Points

Extended Duration

28-35 days for THA/TKA/hip fracture. VTE risk persists beyond discharge. In-hospital only is INADEQUATE.

Mechanical + Chemical

Always combine methods for high-risk. Mechanical reduces VTE by 50% alone. Adding chemical reduces further.

Aspirin Evidence

EPCAT II: Aspirin non-inferior after initial anticoagulant. Can use aspirin to complete extended course after LMWH/DOAC.

Timing Matters

LMWH: 6-12 hours post-op. DOACs: 6-10 hours post-op. Too early = bleeding. Too late = VTE.

Quick Decision Guide

ProcedureVTE RiskProphylaxisDuration
THAVery HighMechanical + LMWH/DOAC35 days
TKAVery HighMechanical + LMWH/DOAC14-35 days
Hip FractureVery HighMechanical + LMWH35 days
Major TraumaHighMechanical + LMWHUntil ambulatory
Foot/AnkleModerateMechanical ± aspirinUntil ambulatory
Mnemonic

MCEVTE Prophylaxis Approach

M
Mechanical
TED + IPC - ALWAYS for high-risk
C
Chemical
LMWH, DOAC, or aspirin
E
Extended
28-35 days for arthroplasty

Memory Hook:MCE = Mechanical, Chemical, Extended - the three pillars of VTE prophylaxis in orthopaedics!

Mnemonic

HIP HIPHigh-Risk VTE Procedures

H
Hip arthroplasty
THA - very high risk
I
Injury to pelvis/hip
Hip fracture - very high
P
Prosthetic knee
TKA - very high risk
H
High spinal surgery
Spinal trauma/fusion
I
Immobilized trauma
Polytrauma
P
Pelvic fractures
Very high risk

Memory Hook:HIP HIP hooray for prophylaxis! These procedures need extended 35-day prophylaxis.

Mnemonic

LEADChemical Prophylaxis Options

L
LMWH
Enoxaparin - gold standard
E
Edoxaban
DOAC option
A
Apixaban/Aspirin
DOAC or aspirin for completion
D
Dabigatran/DOACs
Oral anticoagulants

Memory Hook:LEAD with prophylaxis - LMWH leads as gold standard, DOACs and Aspirin are alternatives!

Overview and Epidemiology

Why VTE Prophylaxis Matters

VTE is the most common preventable cause of in-hospital death. After THA/TKA without prophylaxis, DVT rates are 40-60% and symptomatic PE 1-2%. This is a mandatory exam topic.

Venous Thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE).

Virchow's Triad

  • Stasis: Immobility, surgery, prolonged recumbency
  • Endothelial injury: Surgical trauma, inflammation
  • Hypercoagulability: Surgery-induced, thrombophilia

All three components are present in orthopaedic surgery.

Risk Without Prophylaxis

  • THA: DVT 42-57%, PE 0.9-28%
  • TKA: DVT 41-85%, PE 1.5-10%
  • Hip fracture: DVT 46-60%, fatal PE 3-12%
  • Major trauma: DVT 40-80%

These figures demonstrate why prophylaxis is mandatory.

Pathophysiology and Mechanisms

Thrombosis Anatomy

Most clinically significant DVTs originate in the deep calf veins (soleal sinuses) and propagate proximally. Proximal DVT (popliteal, femoral, iliac) carry highest PE risk. Upper limb DVT is uncommon in orthopaedics.

Deep Vein System:

  • Calf veins: Posterior tibial, peroneal, soleal sinuses (origin of most DVT)
  • Proximal veins: Popliteal, femoral, iliac (highest PE risk)
  • Upper limb: Subclavian, axillary (rare in orthopaedics)

Natural History:

  1. Thrombus forms in calf veins during/after surgery
  2. May propagate proximally (20-30% if untreated)
  3. Proximal DVT can embolize to pulmonary circulation
  4. PE mortality depends on clot burden and cardiopulmonary reserve

Classification Systems

VTE Risk Stratification

Risk LevelProceduresProphylaxisDuration
Very HighTHA, TKA, hip fracture, pelvic traumaMechanical + LMWH/DOAC28-35 days
HighMajor trauma, spine fusion, cancer surgeryMechanical + LMWHUntil ambulatory or 14 days
ModerateFoot/ankle, upper limb, arthroscopyMechanical ± aspirinUntil ambulatory
LowMinor procedures, outpatientEarly mobilizationNone required

Risk stratification guides prophylaxis intensity and duration.

Individual Risk Factors

FactorRelative RiskImplication
Prior VTE5-10xExtended prophylaxis mandatory
Active cancer3-5xConsider LMWH over aspirin
Thrombophilia2-5xScreen if prior VTE or family history
Obesity (BMI greater than 40)2xWeight-based LMWH dosing
Age greater than 701.5xBalance bleeding risk
Immobility greater than 3 days2xAggressive mobilization

Patient factors add to procedural risk.

Clinical Assessment

DVT Signs

  • Calf pain: Worse with dorsiflexion (Homan's sign)
  • Swelling: Asymmetric leg swelling
  • Warmth: Affected limb warmer
  • Erythema: Subtle redness
  • Palpable cord: Thrombosed vein

Clinical signs are unreliable - 50% DVTs are asymptomatic.

PE Signs

  • Dyspnea: Most common symptom
  • Pleuritic chest pain: Sharp, worse on inspiration
  • Tachycardia: Heart rate greater than 100
  • Hypoxia: SpO2 less than 92%
  • Syncope: Massive PE

PE is a clinical emergency - act immediately if suspected.

Clinical Diagnosis is Unreliable

Clinical signs miss 50% of DVTs. Screening is not recommended. Focus on PREVENTION with appropriate prophylaxis rather than detection.

Investigations

Investigation for Suspected VTE

ClinicalRisk Assessment

Wells Score for DVT or PE probability. Guides further investigation.

Blood TestD-dimer

Sensitive but not specific. Useful to rule OUT VTE if negative. Always elevated post-operatively (not useful post-op).

DVT ImagingCompression Ultrasound

Gold standard for DVT. Non-compressible vein = thrombus. Sensitivity greater than 95% for proximal DVT.

PE ImagingCTPA

Gold standard for PE. CT pulmonary angiography. V/Q scan if contrast contraindicated.

Note: D-dimer is NOT useful post-operatively as it is always elevated. Use clinical suspicion and imaging.

Management Algorithm

Mechanical Prophylaxis

Mechanical Methods

StandardTED Stockings

Graduated compression stockings. Below-knee or thigh-high. Reduces DVT by 50% alone. Proper fit essential.

EnhancedIPC (Intermittent Pneumatic Compression)

Sequential calf compression. Apply in OR, continue post-op. More effective than TED alone. Combine with TED for best effect.

AlternativeFoot Pumps

Venous foot pump. Alternative to IPC. May be used if calf access limited.

Mechanical prophylaxis is ALWAYS indicated for high-risk procedures, even with chemical prophylaxis.

Pharmacological Prophylaxis

AgentDoseTimingMonitoring
Enoxaparin (LMWH)40mg SC daily6-12 hrs post-opNone routinely (anti-Xa if renal impaired)
Rivaroxaban10mg PO daily6-10 hrs post-opNone required
Apixaban2.5mg PO BD12-24 hrs post-opNone required
Aspirin100-162mg PO dailyImmediateNone required
Fondaparinux2.5mg SC daily6-8 hrs post-opNone (avoid if CrCl less than 30)

LMWH is gold standard. DOACs are convenient alternatives. Aspirin is acceptable to complete extended course.

Duration Guidelines (AAOS/ACCP)

ProcedureMinimum DurationRecommended
THA10-14 days35 days
TKA10-14 days14-35 days
Hip Fracture28 days35 days
Major TraumaUntil ambulatoryUntil ambulatory
Spine Fusion7-10 daysUntil ambulatory

Extended prophylaxis beyond hospital discharge is MANDATORY for arthroplasty and hip fracture.

Surgical Technique

Surgical Strategies to Reduce VTE

  • Minimize tourniquet time: Longer tourniquet = higher risk
  • Gentle tissue handling: Reduce endothelial injury
  • Regional anesthesia: May reduce VTE vs general
  • Intraoperative IPC: Start before induction
  • Adequate hydration: Avoid hypovolemia
  • Avoid hypotension: Maintain perfusion

These strategies complement mechanical and chemical prophylaxis.

Postoperative VTE Prevention

  • Early mobilization: Weight-bearing day 0-1 when possible
  • Continue IPC: Until ambulatory
  • TED stockings: Bilateral, begin immediately
  • Adequate hydration: Encourage oral fluids
  • Leg elevation: When in bed
  • Active ankle exercises: Hourly when awake

Early mobilization is one of the most effective interventions.

Complications

Complications of Anticoagulation

ComplicationIncidenceManagement
Major bleeding1-3%Hold anticoagulant, reverse if severe, mechanical only
Wound hematoma2-5%May require washout, balance VTE and bleeding risk
HIT (heparin-induced thrombocytopenia)0.5-1%Stop heparin, use fondaparinux or argatroban
Spinal hematomaRareNeurological emergency - decompress urgently
GI bleeding1-2%PPI cover, balance benefits vs risks

HIT is a serious complication of heparin products. Check platelets day 5-10 if using LMWH. If suspected, stop heparin and use alternative (fondaparinux, argatroban).

Postoperative Care

Post-Discharge VTE Prevention

DischargePatient Education

Educate on VTE symptoms. Calf pain, swelling, shortness of breath. Seek immediate help if suspected.

Days 1-14Continue Prophylaxis

Continue LMWH or DOAC as prescribed. Ensure patient understands regimen. Self-injection teaching for LMWH.

Days 14-35Complete Course

May switch to aspirin for completion. Based on EPCAT II evidence. Continue until 35 days total.

Follow-upReassess

Review at follow-up. Stop prophylaxis at 35 days if fully mobile. Continue longer if high-risk or immobile.

Patient compliance with home prophylaxis is essential. Simplify regimens where possible.

Outcomes and Prognosis

With Prophylaxis:

  • DVT: Reduced to 2-5%
  • Symptomatic PE: Less than 0.5%
  • Fatal PE: Less than 0.2%

Prognostic Factors for VTE:

FactorHigher RiskImplication
Prior VTE5-10x baselineConsider extended prophylaxis beyond 35 days
Cancer3-5x baselineLMWH preferred over aspirin
Thrombophilia2-5x baselineHematology input
Bilateral surgery2xHigher dose or longer duration
Transfusion1.5xAdequate prophylaxis

Appropriate prophylaxis makes VTE a rare event after modern arthroplasty.

Evidence Base

Level I RCT
📚 RECORD Trials (1-4)
Key Findings:
  • Rivaroxaban vs enoxaparin for THA/TKA
  • Superior VTE reduction with rivaroxaban
  • Similar major bleeding rates
  • DOACs are effective alternative to LMWH
Clinical Implication: DOACs are non-inferior or superior to LMWH for arthroplasty prophylaxis.
Source: Lancet/NEJM 2008-2009

Level I RCT
📚 EPCAT II
Key Findings:
  • Aspirin vs rivaroxaban to complete extended prophylaxis
  • After initial 5-day rivaroxaban
  • Non-inferior for symptomatic VTE
  • Lower bleeding with aspirin
Clinical Implication: Aspirin can be used to complete extended prophylaxis after initial anticoagulant.
Source: NEJM 2018

Clinical Practice Guideline
📚 ACCP Guidelines
Key Findings:
  • Extended prophylaxis 10-35 days for THA/TKA
  • LMWH, fondaparinux, DOACs, or aspirin acceptable
  • Mechanical prophylaxis recommended for all
  • Balance VTE and bleeding risk
Clinical Implication: Major guidelines support extended prophylaxis with multiple acceptable options.
Source: Chest 2012 (Updated 2016)

Systematic Review
📚 Geerts et al
Key Findings:
  • Meta-analysis of VTE prophylaxis trials
  • LMWH superior to UFH
  • Extended prophylaxis superior to in-hospital only
  • Mechanical adds benefit to chemical
Clinical Implication: Strong evidence supports extended prophylaxis and combined mechanical + chemical approaches.
Source: Chest 2008

Clinical Practice Guideline
📚 AAOS Clinical Practice Guidelines
Key Findings:
  • Patients undergoing elective hip/knee arthroplasty should receive prophylaxis
  • Multiple pharmacological options acceptable
  • Extended duration beyond hospital recommended
  • Mechanical prophylaxis recommended
Clinical Implication: AAOS endorses extended prophylaxis with surgeon choice of agent.
Source: JAAOS 2012

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Scenario 1: THA Prophylaxis Protocol

EXAMINER

"You are planning a primary THA on a 65-year-old man with no prior VTE history. What is your VTE prophylaxis protocol?"

EXCEPTIONAL ANSWER
THA is a very high-risk procedure for VTE. My protocol combines mechanical and pharmacological prophylaxis. Mechanical: I start IPC in the operating theater before induction and continue post-operatively until ambulatory. TED stockings are applied post-operatively and worn continuously. Pharmacological: I start enoxaparin 40mg SC 6-12 hours post-operatively, or rivaroxaban 10mg PO 6-10 hours post-op if preferred for convenience. Duration: I continue prophylaxis for 35 days total. The patient can be discharged on self-injecting enoxaparin or oral rivaroxaban, or can switch to aspirin 100mg after the first 5-7 days to complete the course (EPCAT II evidence). I educate the patient on VTE symptoms and when to seek help.
KEY POINTS TO SCORE
THA = very high VTE risk
Combine mechanical + chemical
Extended prophylaxis 35 days mandatory
Multiple pharmacological options acceptable
COMMON TRAPS
✗In-hospital only prophylaxis is inadequate
✗Forgetting mechanical prophylaxis
✗Not educating patient on symptoms
LIKELY FOLLOW-UPS
"What about aspirin-only prophylaxis?"
"What if the patient has a history of GI bleeding?"
VIVA SCENARIOChallenging

Scenario 2: High Bleeding Risk

EXAMINER

"A 70-year-old woman is undergoing TKA. She has a history of GI bleeding and is on aspirin for coronary artery disease. How do you manage VTE prophylaxis?"

EXCEPTIONAL ANSWER
This patient has high VTE risk from TKA but also high bleeding risk from prior GI bleeding and aspirin use. I would take a balanced approach. First, I would discuss with cardiology about holding aspirin perioperatively if safe - typically aspirin can be held for 7 days post-TKA without excess cardiac risk. For VTE prophylaxis, I would emphasize mechanical methods: TED stockings and IPC started in OR and continued until ambulatory. For pharmacological prophylaxis, I would use a lower-intensity regimen - aspirin 100mg daily may be appropriate given her bleeding history (evidence from EPCAT II supports aspirin efficacy). Alternatively, short-duration rivaroxaban followed by aspirin. I would ensure PPI cover for GI protection. I would counsel about increased bleeding risk but emphasize VTE is still the greater danger. Duration would be 14-35 days.
KEY POINTS TO SCORE
Balance VTE and bleeding risk
Emphasize mechanical prophylaxis
Aspirin may be safer in bleeding-prone patients
PPI cover for GI protection
COMMON TRAPS
✗Avoiding all prophylaxis due to bleeding risk
✗Not addressing the cardiac aspirin
LIKELY FOLLOW-UPS
"What would you do if she developed a DVT?"
"What about a patient on warfarin pre-operatively?"
VIVA SCENARIOCritical

Scenario 3: Suspected PE Post-Arthroplasty

EXAMINER

"Post-operative day 3 after TKA, the patient develops sudden dyspnea and pleuritic chest pain. HR 120, SpO2 88% on room air. What is your approach?"

EXCEPTIONAL ANSWER
This presentation is highly suspicious for pulmonary embolism - a medical emergency. I would immediately call for senior help and the medical emergency team. Initial management: high-flow oxygen, IV access, monitor vitals. I would obtain ECG (look for S1Q3T3, right heart strain), ABG, and urgent CTPA if patient is stable enough. D-dimer is not useful post-operatively. If the patient is unstable (hypotensive), I would consider massive PE and thrombolysis may be needed - I would involve ICU/cardiology urgently. If CTPA confirms PE, therapeutic anticoagulation: LMWH at treatment dose (enoxaparin 1mg/kg BD) or weight-based unfractionated heparin initially, transitioning to oral anticoagulation for 3-6 months minimum. The TKA wound will need careful monitoring for bleeding. I would also investigate for missed DVT with leg ultrasound.
KEY POINTS TO SCORE
PE is a medical emergency - call for help
High-flow O2, IV access, monitoring
CTPA is gold standard investigation
Treatment dose anticoagulation if confirmed
COMMON TRAPS
✗Not recognizing the urgency
✗Using D-dimer post-operatively
✗Delaying treatment while awaiting investigations
LIKELY FOLLOW-UPS
"What is thrombolysis and when would you use it?"
"What anticoagulant would you use long-term?"

MCQ Practice Points

Extended Prophylaxis Duration

Q: How long should VTE prophylaxis continue after THA? A: 28-35 days. VTE risk persists beyond hospital discharge. In-hospital only prophylaxis is inadequate.

LMWH Timing

Q: When should enoxaparin be started after THA? A: 6-12 hours post-operatively. Too early increases bleeding risk. Too late may allow thrombus formation.

Aspirin Evidence

Q: What trial supports aspirin for VTE prophylaxis after arthroplasty? A: EPCAT II (NEJM 2018) showed aspirin is non-inferior to rivaroxaban when used to complete extended prophylaxis after initial anticoagulant.

VTE Risk Without Prophylaxis

Q: What is the DVT rate after THA without prophylaxis? A: 40-60% DVT, 1-2% symptomatic PE. This demonstrates why prophylaxis is mandatory.

Mechanical Prophylaxis Role

Q: What is the role of mechanical prophylaxis in VTE prevention? A: Always use mechanical prophylaxis (TED + IPC) as adjunct. Essential for patients with bleeding contraindications. Start IPC intraoperatively.

HIT Management

Q: How do you manage suspected HIT in a post-arthroplasty patient? A: Stop all heparin immediately. Use non-heparin anticoagulant (fondaparinux, argatroban). Check platelet count and 4T score.

Australian Context

Australian Guidelines:

  • NHMRC Clinical Practice Guidelines support extended prophylaxis
  • TGA-approved agents: enoxaparin, rivaroxaban, apixaban, dabigatran, aspirin
  • Medicare rebates available for VTE prophylaxis agents

State-Specific Protocols:

  • Most Australian public hospitals have VTE prophylaxis protocols
  • Victoria: VENHa (VTE prevention protocols)
  • NSW/QLD: Similar extended prophylaxis recommendations

Medicolegal Considerations:

  • VTE prophylaxis failure is a common medicolegal issue
  • Document risk assessment and prophylaxis plan
  • Document patient education on VTE symptoms
  • Ensure discharge prescription includes extended prophylaxis

PBS Prescribing:

  • Enoxaparin PBS-listed for VTE prophylaxis in major orthopaedic surgery
  • DOACs have specific indications and restrictions
  • Aspirin is over-the-counter

Australian surgeons should follow hospital protocols and ensure extended prophylaxis is prescribed at discharge.

THROMBOPROPHYLAXIS

High-Yield Exam Summary

VTE Risk

  • •THA/TKA/Hip fracture = very high
  • •40-60% DVT without prophylaxis
  • •1-2% symptomatic PE
  • •Risk persists 35 days post-op

Prophylaxis Approach

  • •MCE: Mechanical + Chemical + Extended
  • •TED + IPC for ALL high-risk
  • •LMWH is gold standard
  • •DOACs are equivalent alternatives

Duration

  • •THA: 35 days
  • •TKA: 14-35 days
  • •Hip Fracture: 35 days
  • •NOT just in-hospital

Timing

  • •LMWH: 6-12 hrs post-op
  • •Rivaroxaban: 6-10 hrs post-op
  • •Start IPC in OR
  • •TED immediately post-op

Complications

  • •HIT: Stop heparin, use alternative
  • •Major bleeding: 1-3%
  • •Balance VTE vs bleeding risk
  • •Spinal epidural haematoma with neuraxial anaesthesia
Quick Stats
Reading Time57 min
Related Topics

Blood Management Strategies in Orthopaedic Surgery

Deep Vein Thrombosis - Diagnosis and Treatment

Delirium Prevention in Orthopaedic Surgery

Enhanced Recovery After Surgery (ERAS) Protocols